Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Females With Polycystic Ovary Syndrome
NCT06045351Phase 1Recruiting
- Sponsor
- Aga Khan University
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vitamin d in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Aga Khan University. Primary endpoints: Free Androgen Index at 24 weeks, Homeostatic Model Assessment for Insulin Resistance at 24 weeks and 1 more. Started Jan 2024; status: recruiting.
02
Drugs
vitamin d
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06045351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06045351.